PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsAstrocytoma
MeSH D001254 - astrocytoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D005910:Glioma
9 Companies
2 Drugs
$
Success rate
D001254: 
Astrocytoma
8 Companies
1 Drug
$
Success rate
D005909:Glioblastoma
36 Companies
3 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCisplatin Cisplatin  2000-05-16   
MylanCisplatin Cisplatin  2012-04-18   
Accord HealthcareCisplatin Cisplatin  2015-08-18   
Hikma PharmaceuticalsCisplatin Cisplatin  2000-11-07   
Fresenius KabiCisplatin Cisplatin  1999-07-16   
Gland PharmaCisplatin Cisplatin  2017-03-17   
HQ Specialty PharmaCisplatin Cisplatin  1982-01-01   
Qilu PharmaceuticalsCisplatin Cisplatin  2024-05-10   
Clinical Trials
Historical Success Rate
Phase 1
56%
49/87
Phase 2
19%
15/78
Phase 3
5%
1/21
Approved: 1Overall Success rate: 1%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cisplatin,
GYKI-52466,
TALAMPANEL
Accord Healthcare
Cisplatin
Qilu Pharmaceuticals
Cisplatin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use